288 related articles for article (PubMed ID: 9316843)
1. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
Sudo RT; Nelson TE
J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
[TBL] [Abstract][Full Text] [Related]
2. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
[TBL] [Abstract][Full Text] [Related]
4. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.
Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J
J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556
[TBL] [Abstract][Full Text] [Related]
5. [High purity ryanodine for in vitro diagnosis of malignant hyperthermia].
Wappler F; Roewer N; Lenzen C; Scholz J; Steinfath M; Rumberger R; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Nov; 28(7):427-31. PubMed ID: 8297948
[TBL] [Abstract][Full Text] [Related]
6. [Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].
Gerbershagen MU; Fiege M; Weisshorn R; Kolodzie K; Wappler F
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Mar; 39(3):147-52. PubMed ID: 15042504
[TBL] [Abstract][Full Text] [Related]
7. [Is a presymptomatic malignant hyperthermia in-vitro diagnosis with 4-chloro-3-ethyl phenol possible? A study using porcine skeletal preparations].
Gerbershagen MU; Wappler F; Fiege M; Weisshorn R; Kolodzie K; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):81-6. PubMed ID: 14767797
[TBL] [Abstract][Full Text] [Related]
8. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Hackl W; Winkler M; Mauritz W; Steinbereithner K
Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
[TBL] [Abstract][Full Text] [Related]
9. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
10. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
[TBL] [Abstract][Full Text] [Related]
11. [Ryanodine-induced contractures for the diagnosis of malignant hyperthermia susceptibility].
Lenzen C; Roewer N; Scholz J; Rumberger E; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):459-63. PubMed ID: 1786306
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
[TBL] [Abstract][Full Text] [Related]
13. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle.
Williams JH; Holland M; Lee JC
Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):387-90. PubMed ID: 2385762
[TBL] [Abstract][Full Text] [Related]
14. Ondansetron-induced muscular contractures in malignant hyperthermia-susceptible individuals.
Johannsen S; Roewer N; Schuster F
Anesth Analg; 2012 Oct; 115(4):925-8. PubMed ID: 22696611
[TBL] [Abstract][Full Text] [Related]
15. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
[TBL] [Abstract][Full Text] [Related]
16. In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles.
Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Schulte am Esch J
Anesth Analg; 1996 Jun; 82(6):1230-6. PubMed ID: 8638796
[TBL] [Abstract][Full Text] [Related]
17. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
[TBL] [Abstract][Full Text] [Related]
18. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia].
Weisshorn R; Wappler F; Fiege M; Gerbershagen M; Schulte Am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614
[TBL] [Abstract][Full Text] [Related]
19. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
Nelson TE; Bedell DM; Jones EW
Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
[TBL] [Abstract][Full Text] [Related]
20. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
